Business · 23/07/1996

FDA Approves Biomira Diagnostics' TRUQUANT RIA for Premarket Approval

The US Food and Drug Administration (FDA) has approved Biomira Diagnostics' TRUQUANT RIA for premarket approval, following a recommendation from the Immunology Devices Panel and a notification from the FDA's Center for Devices and Radiological Health (CDRH) on March 29, 1996.